Chloroquine and hydroxychloroquine are drugs that have shown in vitro activity on the
replication of certain coronaviruses. In the context of the SARS-Cov-2 epidemic, the virus …

There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐
19). Early anecdotal reports and limited in vitro data led to the significant uptake of …

Background Coronavirus pandemic is currently a global public health emergency. At
present, no pharmacological treatment is known to treat this condition, and there is a need to …

The world is suffering a respiratory pandemic disease caused by a novel coronavirus (2019-
nCoV), commonly known as COVID-19 (coronavirus disease 2019). The Food and Drug …

The novel coronavirus SARS-CoV-2, causing the disease COVID-19, first emerged in
Wuhan, China in December 2019 and has now spread to 203 countries or territories …

Abstract The coronavirus infection (COVID-19) has turned into a global catastrophe and
there is an intense search for effective drug therapy. Of all the potential therapies …

ABSTRACT COVID-19 has quickly become a public health problem worldwide, and
treatment for this new disease is needed. Hydroxychloroquine is an antimalarial that in vitro …

CONTEXT: Based on the results of preliminary studies, the off-label use of
hydroxychloroquine for COVID-19 infection has been observed in practice. OBJECTIVES: To …

To the editor, Since December 2019, a pandemic outbreak of emerging coronavirus disease
(COVID-19) due to SARS-CoV-2 is spreading, resulting in exponentially increasing numbers …

The COVID-19 pandemic has required clinicians to urgently identify new treatment options
or the re-purposing of existing drugs. Of particular interest are chloroquine (CQ) and …